MAM
Ex-Starcom hand Rajgopal is OMS’ new national buying head
MUMBAI: Gautam Rajgopal, who recently quit Starcom, has joined Optimum Media Solutions (OMS) as the national buying head. Rajgopal was the TV buying head at Starcom.
Speaking to Indiantelevision.com Rajgopal states, “The primary reason was exposure to different markets. Also, the job role is extremely challenging as I will now be handling brands across the country.”
Speaking on the development, OMS president Sandeep Viz says, “Gautam comes with a great deal of experience in the buying space. He’s joined us as a national buyer to integrate buying across the country. He will be responsible for all the strategic brands OMS handles.”
Rajgopal was with Starcom for over 16 months. Prior to that he was with Carat for three and a half years. Rajgopal enjoys an overall experience of over 10 years in the media buying industry.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
